ForeSight is an attempt to revolutionize cancer diagnosis by combining two of science’s newest innovations: AI and genetic sequencing. Despite early cancer detection being one of the most researched topics in the medical field, 20% of cancer diagnoses are incorrect, with 28% of inaccurate or delayed diagnoses leading to death. With this issue in mind, we built a microarray-based cancer diagnosis AI, and trained it to 95% accuracy on a massive dataset of 17,375 human miRNA microarray samples that we compiled from the GEO database. Using statistical methods, we further identified biomarker genes responsible for 12 different types of cancer. With ForeSight, cancer detection can be non-invasive, faster, more accurate, and completely automated.
Hanze (Louis) Wu